#United States #New York #Michael J. Fox #Parkinson's Research #Lasker Award

Michael J. Fox: An Inspiring Advocate in Parkinson's Research

On September 9, 2026, renowned actor and advocate Michael J. Fox received the esteemed Lasker~Bloomberg Public Service Award, honoring his remarkable contributions to Parkinson's disease research. The Michael J. Fox Foundation for Parkinson's Research (MJFF), founded by Fox himself, celebrates this accolade as a recognition of his transformative leadership in the field.

The Lasker Awards are highly regarded in the biomedical community, often seen as a precursor to the Nobel Prize. This particular award is presented to those whose public service expedites advancements in medical science and overall health. The official citation from the Lasker Foundation highlights Fox’s role in 'dispelling the stigma' associated with Parkinson's disease while championing research that has accelerated the discovery of improved therapeutic options.

Reflecting on the honor, Fox expressed his humility and gratitude, emphasizing the collaborative effort involved in this journey. He stated, "I share this honor with everyone who works side by side with us — scientists, policymakers, and most of all, the patients and families who give their all to this cause."

Michael J. Fox was diagnosed with Parkinson's at the young age of 29, which led him to create MJFF in 2000 with a vision to expedite the development of better treatment options. At a time when research efforts faced hurdles, Fox applied an entrepreneurial spirit to philanthropy. He brought together a talented team of scientists, focusing on listening to the needs of patients to steer research towards high-risk, high-reward projects.

Under his guidance, MJFF has grown to become the largest nonprofit entity funding Parkinson's research globally, contributing over $3 billion to date. Their partnerships, such as the Aligning Science Across Parkinson's (ASAP) initiative, further exemplify their commitment to expediting science. Notably, the advice of Lasker and Nobel Laureate Randy Schekman, who nominated Fox, played a pivotal role in this success.

In just two decades of its establishment, the Foundation has drastically reshaped the landscape of Parkinson's research. With an impressive therapeutic pipeline and support for 23 new drug approvals in the last decade, MJFF is now a major player in funding Parkinson's research—a function that surpasses even the contributions from the U.S. federal government.

Additionally, Fox’s advocacy extends beyond direct research funding. In 1999, prior to establishing MJFF, he testified before Congress, urging for increased federal investments in Parkinson's research. He has been a leading voice in promoting the national discourse on stem cell research, ensuring that patients' experiences remain central to the research discussions.

The Foundation’s grassroots advocacy has also seen immense support recently, leading to the passage of the National Plan to End Parkinson's Act in July 2024, marking a significant milestone in federally supported efforts focused on this debilitating disease.

Fox's approach has been all-inclusive, ensuring that those living with Parkinson's have a say in the research that impacts their lives. His candid revelations about his personal journey have broken down stigmas surrounding the condition and empowered patients and their families to engage in shaping the Foundation’s scientific objectives.

This sense of community built by MJFF has grown significantly, now encompassing nearly four million individuals, including 1.2 million donors who reflect Fox's exceptional ability to galvanize collective support.

Fox’s recognition through the Lasker Award is a testament to his enduring commitment to humanitarian leadership. Since his diagnosis, he has transformed his personal challenge into a rallying point, urging for greater focus on research and meaningful patient engagement. His numerous accolades, including the Presidential Medal of Freedom and several honorary degrees, further underline the impact of his work and advocacy.

The Lasker Foundation has been honoring leaders in medical advancement since 1945, with more than 400 prizes awarded. The Lasker~Bloomberg Public Service Award, accompanied by a $250,000 honorarium, underscores the significance of such contributions. The gala ceremony, where Fox will be commemorated, will take place in New York City on September 17, 2026, further highlighting the urgent need for continued support in the fight against Parkinson's disease.

For additional information on the work of The Michael J. Fox Foundation and ongoing research efforts, please visit www.michaeljfox.org.